Evaluation of the sensitivity to endocrine therapy index (SET2,3) for response to neoadjuvant endocrine therapy (NET) and subsequent prognosis. (Alliance)
      Google Scholar   
Citation:
J Clin Oncol vol 39 (no. 15_suppl) 580
Meeting Instance:
ASCO 2021
Year:
2021
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
Yes
Parents:
None
Children:
3692  
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                   
Networks:
LAPS-MO011, LAPS-TX035, TX041   
Study
ACOSOG-Z1031
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: